Mouth Ulcer Treatment Market Analysis - Global Forecast 2026 | Bristol-Myers Squibb Company, GlaxoSmithKline plc Pfizer, Inc., ECR Pharmaceuticals Co. Inc., Colgate-Palmolive Company

According to the British Dental Journal estimates of 2012, recurrent mouth ulcers affect 15% to 30% of the global population with frequency of 50% people from all age groups. The increasing awareness about the serious condition of mouth ulcers, extensive promotional activity programs, and easy availability of treatments products like gels and lozenges are estimated to fuel the growth of the global market in the forecast period. In addition, lack of knowledge of maintaining mouth hygiene and rising number of cases owing to the aging population are expected to accelerate the growth of the mouth ulcers market across the globe.

Technical advancements in the field of dental care, rise in the use of pharmaceuticals for oral treatment fuel the market growth. The factors driving the global mouth ulcers treatment market are higher prevalence of mouth ulcers, increasing disease and treatment awareness, and rising adoption of pharmaceuticals as a treatment option. Gel formulations are the first line treatment largely prescribed to the patients owing to its ease of availability

Get Exclusive Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/701

Rising number of mergers, acquisitions and new product launches are the latest trends adopted by the companies in the global mouth ulcers treatment market.

Leading companies include

1 Bristol-Myers Squibb Company
2 GlaxoSmithKline plc
3 Pfizer
4 ECR Pharmaceuticals Co
5 Colgate-Palmolive Company

Regional segmentation of the global mouth ulcers treatment market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East and Africa. According to the Journal of Oral Pathology and Medicine in 2013, around 49.7% women and 38.7% men were suffering from aphthous stomatitis in the U.S., thus increasing the demand of mouth ulcers treatment market in North America.

North America dominates the market, due to augmented use of intra-oral cameras, digital X-rays, optical scanners, and computer assisted designs in the field of dentistry. Growing economies and demographics in the Asia Pacific is expected to boost the opportunities in this market.

Read Full Report with TOC @ https://www.coherentmarketinsights.com/ongoing-insight/toc/701

The global mouth ulcers treatment market is segmented on the basis of drug type, formulation, indication and geography.

On the basis of drug type, the global mouth ulcers treatment market is segmented into:
Corticosteroid
Antihistamine
Antimicrobial
Analgesic
Anesthetic

On the basis of formulation, the global mouth ulcers treatment market is segmented into:
Gel
Mouthwash
Ointment
Spray
Lozenges

On the basis of indication, the global mouth ulcers treatment market is segmented into:
Aphthous Stomatitis
Oral Lichen Planus
Others

Ask Questions to Expertise @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/701

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.